Find out more at btsub.sg/btdeal
You are here
FDA deal allows Amarin to promote drug for off-label use
IN a deal that could change the way some companies market their drugs, the Food and Drug Administration has agreed to allow a pharmaceutical company to promote a drug for a use that the agency has not approved, the company said on Tuesday.
The agreement settles a legal
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org